In vitro haemocompatibility of a novel bioprosthetic total artificial heart
European Journal of Cardio-Thoracic Surgery, 05/21/2012Jansen P et al.
Haemocompatibility of the TAH blood–contacting surfaces was confirmed by in vitro studies showing a limited consumption of fibrin, limited thromboxane B2 release and platelet adhesion, and minor blood cell depositions on the surfaces. These results will be validated in clinical studies, with the aim of reducing anti–coagulation when using the CARMAT TAH.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.